As news of the latest clinical trial results and fundraising milestones continues to roll in, it valuable to take a step back and consider the crucial numbers further down the road-- the pricing of the drugs themselves, and the total cost of providing care. In this session, we will hear an economic analysis of these potential costs, and how they will affect the size and shape of the market.